Advertisement
Screener

SYNLOGIC, INC. (SYBX) Common Stock, Capital Shares Reserved for Future Issuance

SYNLOGIC, INC. Common Stock, Capital Shares Reserved for Future Issuance

SYNLOGIC, INC. (SYBX) had Common Stock, Capital Shares Reserved for Future Issuance of 8.33 million shares as of 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Notes › Stockholders' Equity Note

us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-11

  • 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 8.33M shares.
  • 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 8.33M shares.
  • 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 8.32M shares.
  • 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 8.31M shares.
Period endCommon Stock, Capital Shares Reserved for Future Issuance
2026-06-308.33M shares
10-Q · filed 2026-08-11
2026-03-318.33M shares
10-Q · filed 2026-05-14
2025-12-318.32M shares
10-K · filed 2026-03-12
2025-09-308.31M shares
10-Q · filed 2025-11-13
2025-06-308.36M shares
10-Q · filed 2025-08-07
2024-12-318.35M shares
10-K · filed 2025-03-06
2024-09-308.41M shares
10-Q · filed 2024-11-12
2024-06-304.92M shares
10-Q · filed 2024-08-08
2024-03-314.98M shares
10-Q · filed 2024-05-14
2023-12-317.23M shares
10-K · filed 2024-03-19
2023-09-30462.68K shares
10-Q · filed 2023-11-09
2023-06-306.82M shares
10-Q · filed 2023-08-10
2023-03-316.07M shares
10-Q · filed 2023-05-11
2022-12-315.93M shares
10-K · filed 2023-03-29
2022-09-305.58M shares
10-Q · filed 2022-11-10
2022-06-305.28M shares
10-Q · filed 2022-08-11
2022-03-314.83M shares
10-Q · filed 2022-05-12
2021-12-314.60M shares
10-K · filed 2022-03-17
2021-09-304.41M shares
10-Q · filed 2021-11-10
2021-06-304.38M shares
10-Q · filed 2021-08-12
2021-03-314.92M shares
10-Q · filed 2021-05-13
2020-12-314.11M shares
10-K · filed 2021-03-25
2015-09-3011.69M shares
10-Q · filed 2015-11-13
2014-12-316.19M shares
10-Q · filed 2015-11-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Bolt Biotherapeutics, Inc. (BOLT)United States$0.007B-0.26
Enveric Biosciences, Inc. (ENVB)United States$0.007B-0.63
Acurx Pharmaceuticals, Inc. (ACXP)United States$0.007B-0.97
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B
Apimeds Pharmaceuticals US, Inc. (APUS)United States$0.008B
InMed Pharmaceuticals Inc. (INM)$0.008B-0.65
Ernexa Therapeutics Inc. (ERNA)United States$0.006B
Ensysce Biosciences, Inc. (ENSC)United States$0.008B-0.37
Pulmatrix, Inc. (PULM)United States$0.006B
EXICURE, INC. (XCUR)United States$0.008B-1.54